Shares of Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF – Get Free Report) shot up 2.9% on Monday . The company traded as high as $9.36 and last traded at $9.36. 500 shares traded hands during trading, a decline of 17% from the average session volume of 600 shares. The stock had previously closed at $9.10.
Newron Pharmaceuticals Stock Up 2.9 %
The company’s 50 day moving average price is $10.56 and its two-hundred day moving average price is $10.04.
Newron Pharmaceuticals Company Profile
Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.
Featured Stories
- Five stocks we like better than Newron Pharmaceuticals
- Buy P&G Now, Before It Sets A New All-Time High
- Why Block’s Key Components Make It a Solid Investment Choice
- Using the MarketBeat Stock Split Calculator
- Is Applied Digital’s Stock Set to Surge With NVIDIA’s Backing?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 4 Reasons to Consider Adding General Mills to Your Portfolio
Receive News & Ratings for Newron Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newron Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
